Cell signaling enables cells to communicate and coordinate responses to their environment. A signaling molecule (ligand) binds a specific receptor, triggering a conformational change that initiates an intracellular cascade. Signal transduction involves three stages: reception (ligand-receptor binding), transduction (amplification cascade, often involving second messengers like cAMP or protein kinases), and response (changes in gene expression, metabolism, or cell behavior). Receptor types include G protein-coupled receptors, receptor tyrosine kinases, and intracellular receptors (for lipid-soluble signals). Signal amplification allows minute ligand concentrations to produce large cellular responses.
Trace the adenylyl cyclase pathway from epinephrine binding → GPCR activation → adenylyl cyclase → cAMP → PKA → target enzymes. Count amplification steps to appreciate how one hormone molecule activates millions of enzyme molecules.
Cells don't operate in isolation — they constantly receive instructions from neighboring cells, distant organs, and the external environment. The fundamental challenge is physical: most signaling molecules are large or water-soluble and cannot cross the hydrophobic lipid bilayer. You already know from cell membrane structure that the bilayer is selectively permeable, and from enzyme function that molecular shape determines binding. Cell signaling solves the communication problem with a relay: a signal molecule binds a surface receptor, and the receptor triggers an entirely intracellular chain of events. The message crosses the membrane indirectly.
Signal transduction unfolds in three stages. Reception: a ligand (hormone, neurotransmitter, or local signal molecule) binds its specific receptor with high specificity — shape complementarity ensures that only the correct molecule fits. Transduction: the bound receptor changes conformation, activating downstream proteins. These activate other molecules, which activate still more — each step can amplify the signal, with one activated kinase phosphorylating hundreds of substrate molecules before it is switched off. Response: the amplified signal reaches its target, whether that means opening an ion channel, activating gene transcription, triggering cell division, or reshaping metabolism.
A pervasive misconception is that hormones enter cells. Most don't. Only lipid-soluble hormones — steroids like cortisol and estrogen, and thyroid hormone — dissolve through the membrane and bind intracellular receptors, often in the nucleus where they directly influence gene expression. Peptide hormones like insulin, epinephrine, and glucagon are hydrophilic; they bind surface receptors and never enter the cell. They don't need to: the signal transduction cascade carries their message inside.
Second messengers like cyclic AMP (cAMP) and calcium ions are the intracellular relay molecules that make this work. When epinephrine binds its GPCR, the activated G protein stimulates adenylyl cyclase, which converts many ATP molecules into cAMP. Each cAMP activates a protein kinase A (PKA) molecule, which phosphorylates many downstream enzymes. One hormone molecule can thus trigger the release of millions of glucose units from glycogen — enormous amplification from a minute signal.
Signals must also be terminated — cells cannot remain in a permanently activated state. Phosphodiesterases degrade cAMP; protein phosphatases remove the phosphate groups that kinases added; intrinsic GTPase activity in G proteins hydrolyzes GTP to GDP, switching them off. Signal termination is as tightly regulated as initiation, and disruption of either phase underlies major diseases: uncontrolled cell proliferation (cancer) often involves stuck-on kinase signals, while conditions like type 2 diabetes involve blunted receptor responses.